Arca
Skip to content
Tools
Tools

-rolimus

Immunosuppressants related to sirolimus (rapamycin).

  • Drugs ending in -rolimus: 9
  • Approved somewhere: 5
  • With a US drug page: 4

What it means

Stem from WHO's stem book, 2024; description by Arca
Stem
-rolimus
Class
Immunosuppressants related to sirolimus (rapamycin)
Sub-stem of
-imus: Immunosuppressants used outside cancer care
Most common targets
FKBP1A (7), MTOR (1)

Drugs that carry it

Approved and clinical-stage drugs in ChEMBL whose names ending in -rolimus, matched by spelling; those with a US drug page link to it.
Acts on
EverolimusApprovedFKBP1AFK506-binding protein 1A inhibitor
PimecrolimusApprovedFKBP1AFK506-binding protein 1A inhibitor
SirolimusApprovedFKBP1AFK506-binding protein 1A inhibitor
TemsirolimusApprovedFKBP1AFK506-binding protein 1A inhibitor
Tacrolimus anhydrousApprovedFKBP1AFK506-binding protein 1A inhibitor
RidaforolimusPhase 3MTORSerine/threonine-protein kinase mTOR inhibitor
LaporolimusPhase 1——
Olocrolimus—FKBP1AFK506-binding protein 1A inhibitor
Zotarolimus—FKBP1AFK506-binding protein 1A inhibitor

Stem from WHO, The use of stems in the selection of International Nonproprietary Names (INN) for pharmaceutical substances (2024); description written by Arca. Drugs, stages, targets and mechanisms from ChEMBL (CC BY-SA 3.0). WHO

Esc

Type a name: a tool, a company, a drug or brand, a condition, a gene or a state. Identifiers like K231234, NCT05012345 or NDA 215866 open their record.

Logos are each company's own site icon, matched by name through Wikidata, or logos provided by Logo.dev.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.